SCHEMBL21189188

SCHEMBL21189188

O=C(Nc1ccc(F)c(Cl)c1)c1ccc(F)c2c1OCC[C@@H]2NCl

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
FADS1 O60427 1/20 0.46
NPC1 O15118 5/20 0.46
RAB9A P51151 5/20 0.46
KMT2A Q03164 5/20 0.46
MEN1 O00255 3/20 0.46
ALDH1A1 P00352 2/20 0.46
NPSR1 Q6W5P4 1/20 0.44
MAPT P10636 2/20 0.42
ENPP2 Q13822 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
NR1I2 O75469 1/20 0.42
AHR P35869 1/20 0.42
LMNA P02545 2/20 0.42
HTT P42858 1/20 0.42
GAA P10253 1/20 0.42
TP53 P04637 1/20 0.42
SLC2A1 P11166 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19973411 0.90 KMT2A (0.46) FADS1NPC1RAB9AKMT2AMEN1
SCHEMBL19973456 0.90 KMT2A (0.46) FADS1NPC1RAB9AKMT2AMEN1
SCHEMBL19973410 0.90 KMT2A (0.46) FADS1NPC1RAB9AKMT2AMEN1
Hydrochloric Acid SCHEMBL19973481 0.89 KMT2A (0.46) FADS1NPC1RAB9AKMT2AMEN1
Hydrochloric Acid SCHEMBL19973482 0.89 KMT2A (0.46) FADS1NPC1RAB9AKMT2AMEN1
SCHEMBL21189197 0.88 HTR2B (0.42) NPC1RAB9AKMT2AMEN1ALDH1A1
SCHEMBL21189275 0.87 NPC1 (0.46) FADS1NPC1RAB9AKMT2AMEN1
SCHEMBL21189195 0.87 NPC1 (0.46) FADS1NPC1RAB9AKMT2AMEN1
SCHEMBL19973489 0.87 KMT2A (0.47) FADS1NPC1RAB9AKMT2AMEN1
SCHEMBL19973490 0.87 KMT2A (0.47) FADS1NPC1RAB9AKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11001564-B2 Substituted chromane-8-carboxamide compounds and analogues thereof, and methods using same ARBUTUS BIOPHARMA CORPORATION (CA) 2021-05-11 US disclosed
US-20190225593-A1 SUBSTITUTED CHROMANE-8-CARBOXAMIDE COMPOUNDS AND ANALOGUES THEREOF, AND METHODS USING SAME ARBUTUS BIOPHARMA CORP (CA) 2019-07-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190225593-A1 SUBSTITUTED CHROMANE-8-CARBOXAMIDE COMPOUNDS AND ANALOGUES THEREOF, AND METHODS USING SAME CBX8, HAVCR2, HCCS FADS1 2483/4885NPC1 983/4885RAB9A 1393/4885
US-11001564-B2 Substituted chromane-8-carboxamide compounds and analogues thereof, and methods using same CBX8, HAVCR2, HCCS FADS1 2483/4885NPC1 983/4885RAB9A 1393/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.